Elite Pharmaceuticals (ELTP) Work In Process (2018 - 2026)
Elite Pharmaceuticals' Work In Process was $2.13 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 6.8% from $2 million a year earlier but down 34.7% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Work In Process (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Work In Process at Elite Pharmaceuticals came in at $3.27 million, up 129.8% from FY2025.
- Work In Process shows a five-year compound annual growth rate of 33.1% (FY2021 to FY2026).
- In earlier fiscal years, Work In Process was $1.42 million in FY2025 (-21.2%), $1.8 million in FY2024 (+0.7%), $1.79 million in FY2023 (+48.9%) and $1.2 million in FY2022 (+54.0%).
- Quarterly Work In Process has moved between $966.00 (fiscal Q3 2022) and $3.65 million (fiscal Q3 2026) over five years.
- Compared with a year earlier, Work In Process has increased for four straight quarters, with growth averaging 39.2% over the last eight quarters.
- The best year-over-year quarter for Work In Process over five years was fiscal Q4 2026 (growth of 129.8%); the worst was fiscal Q3 2022 (a decline of 97.8%).
- Per Business Quant data, ELTP's Work In Process in the three fiscal quarters before Q1 2027 was $3.27 million (Q4 2026), $3.65 million (Q3 2026) and $2.26 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.13 Mn |
| Mar 31, 2026 | 3.27 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 1.80 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 90,922.00 |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 99,283.00 |
| Sep 30, 2022 | 95,707.00 |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 966.00 |
| Sep 30, 2021 | 1,722.00 |
| Jun 30, 2021 | 31,629.00 |
API Access
Elite Pharmaceuticals Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();